The global chronic wound care market was valued at USD 12.86 billion in 2022 and it is predicted to surpass around USD 19.16 billion by 2032 with a CAGR of 4.07% from 2023 to 2032.
Report Highlights
Diabetes may increase the overall frequency and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and chronic wounds, including surgical & traumatic wounds. For instance, according to a research article published in March 2021 by ScienceDirect, the prevalence of diabetes is expected to increase to 120 million people in 2032, thereby propelling market growth.
The outbreak of COVID-19 has created large-scale opportunities for local manufacturers. Due to the restrictions on movement at international borders, the supply chain of major players has been disrupted. This has created an opportunity for local players to enter the market and meet the unmet demands of the end-users. The rising number of cases has led to a shortage of medical supplies; thus, local players are manufacturing products on a larger scale to meet the growing need. Moreover, to enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share.
Technological advancements are projected to have a significant impact on the advanced wound care industry in the coming years. The quality of life of patients suffering from chronic wounds improves as technology advances and becomes more affordable. Traditional wound care and closure products are gradually being replaced by advanced wound care & closure products due to their efficacy and effectiveness in wound management by allowing quicker healing.
Report Coverage | Details |
Market Size in 2022 | USD 12.86 billion |
Revenue Forecast by 2032 | USD 19.16 billion |
Growth rate from 2023 to 2032 | CAGR of 4.07% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segmentation | Product, application, end-use, region |
Companies Covered | Johnson & Johnson; Baxter International; Coloplast Corp.; 3M; Medline Industries, Inc.; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Mölnlycke Health Care AB; Paul Hartmann AG; Smith & Nephew PL |
Product Insights
Advanced wound dressing dominated the product segment of the market with a market share of 35.1% in 2022 and is expected to witness the fastest growth over the forecast period due to an increase in technological advancement, rising cases of chronic diseases, and an increase in the number of sports-related injuries.
Based on products, the wound care market is segmented into traditional wound dressings, advanced wound dressings, surgical wound dressings, and wound therapy devices. The market is expected to witness significant growth owing to the increasing prevalence of chronic diseases such as diabetic foot ulcers and venous leg ulcers. Moreover, the rising geriatric population across the globe is also expected to boost the market growth. Increasing awareness of surgical site infection and rising disposable income are other major factors that are expected to foster market growth.
Foam dressing helps in absorbing the moisture that aids in maintaining the integrity of the tissue. The increasing cases of trauma and pressure ulcer patients across the globe are expected to propel the segment growth. For instance, as per the Agency for Healthcare Research and Quality, every year, more than 2.5 million people in the U.S. develop pressure ulcers. Foams are mainly used to protect skin breakdown due to friction, aiding chronic wound management and propelling the segment growth over the forecast period.
End-use Insights
In 2022, based on end-use, the hospital segment accounted for the maximum revenue share with around 46.03% owing to the increasing number of surgeries, globally. However, the home healthcare segment is anticipated to witness the fastest growth rate of 4.90% during the forecast period due to the increase in demand for reduced hospital stays.
Increasing surgical procedures, rising incidence of diabetic foot ulcers, and an increasing number of hospitals are among the major factors driving the segment growth. As per the latest survey by the American Hospital Association, the total number of hospitals in the U.S. is estimated to be 6,093 in 2022. Similarly, as per reports, there has been a constant increase in the number of hospitals in the U.K., as the number of hospitals has increased to 1,978 in 2019. Thus, such factors may increase the number of surgeries, and therefore may surge the segment growth over the forecast period.
Wound care in homecare settings was majorly initiated with the introduction of single-use NPWT systems. These devices are lightweight, portable, canister-free, and easy to use. In addition, the cost-effectiveness of such therapy for treating wounds also encourages patients to adopt homecare settings over hospital stays.
Application Insights
Based on application, the diabetic foot ulcers segment dominated the market in 2022 with a market share of 35.03%. This can be attributed to the increase in the number of diabetic patients globally. However, the pressure ulcers segment is anticipated to witness the fastest growth over the forecast period owing to the increasing prevalence of obesity and related wounds.
Pressure ulcers are injuries to the skin and underlying tissues, which are a result of prolonged pressure on the skin. This can be caused due to prolonged hospitalization and being unable to move, which especially happens in old age and in case of sudden weight loss. For instance, according to Agency for Healthcare Research and Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year. Similarly, according to NCBI, the incidence of pressure ulcers in a clinical setting may range from 4.0% to 38.0%. In addition, according to a similar source, the mortality rate due to pressure ulcers and associated disorders is estimated to be approximately 68.0% in adults. As the geriatric population is more vulnerable to pressure ulcers, an increase in the geriatric population may lead to a rise in the number of pressure ulcer patients, which is expected to propel segment growth over the forecast period.
Regional Insights
North America was identified as the most revenue-generating region in 2022 with over 45.11% share of the chronic wound care market. Increasing sports injuries, road accidents, and the presence of several key players in the region are anticipated to drive the market in North America. For instance, as per the National Institute of Diabetes and Digestive Kidney Diseases, an estimated 34.2 million people have diabetes, which comprises 10.5% of the U.S. Additionally, 88 million adults people aged 18 years & older have prediabetes, which may further increase the chronic diseases in this region. Similarly, the availability of skilled professionals, improvement in healthcare infrastructure, and presence of major market players are also expected to drive the market over the forecast period.
Asia Pacific wound care market is anticipated to witness the fastest growth over the forecast period. The presence of developing countries such as China, India, and Japan is anticipated to boost market growth in the Asia Pacific region. In addition, with a rapidly aging population in this region, along with an increasing number of obese and diabetic patients, the use of chronic wounds in this region is anticipated to increase. Moreover, medical tourism in this region has also been attributed to the increase in demand for chronic wound care products.
The rising geriatric population is one of the major driving factors for the market growth in Japan. According to Europa, more than one in four people are above 65 years of age. As the geriatric population is at a higher risk of various diseases and disabilities, an increase in the elderly population may propel the demand for wound care products.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Chronic Wound Care Market
5.1. COVID-19 Landscape: Chronic Wound Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Chronic Wound Care Market, By Product
8.1. Chronic Wound Care Market, by Product, 2023-2032
8.1.1 Advanced Wound Dressing
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Surgical Wound Care
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Traditional Wound Care
8.1.3.1. Market Revenue and Forecast (2019-2032)
8.1.4. Wound Therapy Devices
8.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Chronic Wound Care Market, By Application
9.1. Chronic Wound Care Market, by Application, 2023-2032
9.1.1. Diabetic Foot Ulcers
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Pressure Ulcers
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Venous Leg Ulcers
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Chronic Wound Care Market, By End-use
10.1. Chronic Wound Care Market, by End-use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Chronic Wound Care Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2032)
11.1.2. Market Revenue and Forecast, by Application (2019-2032)
11.1.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2032)
11.2.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2032)
11.3.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2032)
11.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2032)
11.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 12. Company Profiles
12.1. JOHNSON & JOHNSON
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BAXTER INTERNATIONAL
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Coloplast Corp.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. 3M
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Medline Industries, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ConvaTec Group PLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Derma Sciences (Integra LifeSciences)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Mölnlycke Health Care AB
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Paul Hartmann AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Paul Hartmann AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms